Skip to main content

Table 1 Baseline characteristics by treatment group

From: Safety and feasibility of a Dalcroze eurhythmics and a simple home exercise program among older adults with mild cognitive impairment (MCI) or mild dementia: the MOVE for your MIND pilot trial

Variable

Dalcroze (n = 7)

SHEP (n = 5)

Control (n = 6)

Age, years

75.9 (5.1)

73.8 (3.6)

76.7 (4.8)

Female gender, n (%)

4 (57.1)

3 (60.0)

4 (66.7)

Fall history last 12 months, n (%)

4 (57.1)

2 (40.0)

3 (50.0)

Cognitive function

   

 Diagnosis of MCI, n (%)

3 (42.9)

2 (40.0)

1 (16.7)

 Diagnosis of mild dementia, n (%)

4 (57.1)

3 (60.0)

5 (83.3)

 MoCA score (max. 30)

19.6 (2.9)

22.6 (3.0)

20.0 (1.9)

Gait speed, cm/s

   

 Single task

103.3 (20.8)

104.4 (31.6)

112.0 (13.8)

 Dual-task working memory

90.2 (19.0)

114.5 (19.3)

88.3 (17.2)

 Dual-task semantic memory

94.5 (73.4–106.5)

128.5 (78.9–149.1)

94.5 (73.4–106.5)